MedTrace Logo

Adapted RPM-08 for Substance Use Disorder in Pakistan

NCT07552623 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-04-27

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a culturally adapted Relapse Prevention Module (RPM-08) can reduce relapse risk in people with substance use disorders in Pakistan. The study also examines whether the adapted intervention is effective over time.

The main questions it aims to answer are:

Does the adapted RPM-08 reduce relapse risk compared to usual treatment? Are the effects of the intervention maintained after a follow-up period?

Researchers compared participants who received the adapted RPM-08 along with usual treatment to those who received usual treatment only to see if the intervention improves relapse outcomes.

Participants will:

Attend eight structured group sessions over eight weeks Receive usual treatment provided by the rehabilitation center Complete questionnaires at baseline, after the intervention, and at follow-up

Conditions

  • Substance Use Disorder (SUD)
  • Drug Abuse
  • Relapse

Interventions

BEHAVIORAL

Adapted Relapse Prevention Module (RPM-08)

The adapted Relapse Prevention Module (RPM-08) is a structured cognitive-behavioral intervention designed to reduce relapse risk among individuals with substance use disorders. It is based on relapse prevention principles and the stages of change model, focusing on identifying high-risk situations, recognizing early warning signs, and developing coping strategies. The intervention was culturally adapted for the Pakistani context and delivered in a group format. It consisted of eight structured sessions conducted over eight weeks. The sessions included psychoeducation, cognitive restructuring, emotional regulation, coping skills training, and relapse prevention planning. Cultural adaptations incorporated locally relevant examples, family-oriented perspectives, and context-specific coping strategies to enhance engagement and applicability.

OTHER

Treatment as Usual (TAU)

Standard rehabilitation care provided by the treatment facility, including medical monitoring, counselling sessions, and psychosocial support services.

Sponsors & Collaborators

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Rabab Zahra, PhD Candidate (Psychology) · Universiti Utara Malaysia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
56 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-04
Primary Completion
2024-02-28
Completion
2024-04-13

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07552623 on ClinicalTrials.gov